A Dose-Ranging Clinical Study to Assess the Safety and Efficacy of Subconjunctival Injection of Sirolimus in Patients With Dry Eye in the Controlled Adverse Environmental (CAE) Model
Completed · Phase 2 · Has a placebo group
Conditions studied: Dry Eye
In brief
The purpose of this study is to determine the safety and efficacy of an ocular sirolimus (rapamycin) formulation compared to Placebo on the signs and symptoms of dry eye in the CAE Model.
Key facts
- Study ID
- NCT00814944
- Run by
- Santen Inc.
- People needed
- 143
- Starts
- 2009-04-01
- Expected to finish
- 2009-10-01
- Last updated by the study team
- 2013-01-10
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Ophthalmic Research Associates — Andover, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.